Assessing the link between BACH1 and BRCA1 in the FA pathway - PubMed (original) (raw)
Review
doi: 10.4161/cc.5.2.2338. Epub 2006 Jan 16.
Affiliations
- PMID: 16357529
- DOI: 10.4161/cc.5.2.2338
Review
Assessing the link between BACH1 and BRCA1 in the FA pathway
Sharon B Cantor et al. Cell Cycle. 2006 Jan.
Abstract
The BACH1 helicase was initially identified by its direct binding to BRCA1 and, thus, was linked to hereditary breast cancer. More recently, BACH1 was identified as the gene defective in the J complementation group of Fanconi anemia (FA). FA is a multigenetic disorder characterized by cellular sensitivity to crosslinkers and chromosome instability. Because FANCD2 monoubiquitination is intact in BACH1 deficient cells, BACH1 appears to act downstream in the FA pathway akin to BRCA2/FANCD1. Interestingly, while BRCA1 has various interactions with FA proteins it has not been identified as an FA gene. As the race to uncover the last few unknown FA complementation groups comes to an end, future work will be required to uncover how these gene products function to combat the effects of DNA damage and maintain genomic stability. In particular, it remains elusive whether BRCA1 is functionally linked to the FA pathway through its interaction with BACH1/FANCJ. This review focuses on a model for the connection of BRCA1 to BACH1 in the FA pathway. We predict that BRCA1 regulates the BACH1 helicase activity to coordinate the timely displacement of Rad51 from nucleofilaments, promoting error free repair and ultimately maintaining chromosomal integrity.
Similar articles
- FANCJ helicase operates in the Fanconi Anemia DNA repair pathway and the response to replicational stress.
Wu Y, Brosh RM Jr. Wu Y, et al. Curr Mol Med. 2009 May;9(4):470-82. doi: 10.2174/156652409788167159. Curr Mol Med. 2009. PMID: 19519404 Free PMC article. Review. - BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
Dohrn L, Salles D, Siehler SY, Kaufmann J, Wiesmüller L. Dohrn L, et al. Biochem J. 2012 Feb 1;441(3):919-26. doi: 10.1042/BJ20110314. Biochem J. 2012. PMID: 22032289 - The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells.
Peng M, Litman R, Xie J, Sharma S, Brosh RM Jr, Cantor SB. Peng M, et al. EMBO J. 2007 Jul 11;26(13):3238-49. doi: 10.1038/sj.emboj.7601754. Epub 2007 Jun 21. EMBO J. 2007. PMID: 17581638 Free PMC article. - Activation of BRCA1/BRCA2-associated helicase BACH1 is required for timely progression through S phase.
Kumaraswamy E, Shiekhattar R. Kumaraswamy E, et al. Mol Cell Biol. 2007 Oct;27(19):6733-41. doi: 10.1128/MCB.00961-07. Epub 2007 Jul 30. Mol Cell Biol. 2007. PMID: 17664283 Free PMC article. - FANCM-FAAP24 and FANCJ: FA proteins that metabolize DNA.
Ali AM, Singh TR, Meetei AR. Ali AM, et al. Mutat Res. 2009 Jul 31;668(1-2):20-6. doi: 10.1016/j.mrfmmm.2009.04.002. Epub 2009 Apr 18. Mutat Res. 2009. PMID: 19379763 Free PMC article. Review.
Cited by
- FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses.
Zhang F, Fan Q, Ren K, Auerbach AD, Andreassen PR. Zhang F, et al. Chromosoma. 2010 Dec;119(6):637-49. doi: 10.1007/s00412-010-0285-6. Epub 2010 Jul 31. Chromosoma. 2010. PMID: 20676667 Free PMC article. - Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass.
Xie J, Litman R, Wang S, Peng M, Guillemette S, Rooney T, Cantor SB. Xie J, et al. Oncogene. 2010 Apr 29;29(17):2499-508. doi: 10.1038/onc.2010.18. Epub 2010 Feb 22. Oncogene. 2010. PMID: 20173781 Free PMC article. - Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy.
Andreassen PR, Ren K. Andreassen PR, et al. Curr Cancer Drug Targets. 2009 Feb;9(1):101-17. doi: 10.2174/156800909787314011. Curr Cancer Drug Targets. 2009. PMID: 19200054 Free PMC article. Review. - Chl1 DNA helicase regulates Scc2 deposition specifically during DNA-replication in Saccharomyces cerevisiae.
Rudra S, Skibbens RV. Rudra S, et al. PLoS One. 2013 Sep 26;8(9):e75435. doi: 10.1371/journal.pone.0075435. eCollection 2013. PLoS One. 2013. PMID: 24086532 Free PMC article. - PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers?
De Soto JA, Deng CX. De Soto JA, et al. Int J Med Sci. 2006 Jul 15;3(4):117-23. doi: 10.7150/ijms.3.117. Int J Med Sci. 2006. PMID: 16906222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous